Objective: Pancreatic cancer is a highly lethal malignancy globally. This study aimed to
probe and validate immune-related prognostic mRNAs as therapeutic targets for pancreatic …

Background. The prognosis of pancreatic adenocarcinoma (PAAD) is extremely poor and
has not been improved. Thus, an effective method to assess the prognosis of patients must …

Background Pancreatic adenocarcinoma (PAAD) is a highly lethal and aggressive tumor
with poor prognoses. The predictive capability of immune-related genes (IRGs) in PAAD has …

Objective: The tumour microenvironment is one of the significant factors driving the
carcinogenesis of Pancreatic adenocarcinoma (PAAD). However, the underlying …

Pancreatic cancer is one of the most lethal malignancies. With the promising prospects
conveyed by immunotherapy in cancers, we aimed to construct an immune‐related gene …

Abstract Background Immune-related genes (IRGs) are associated with the prognosis of
different cancers and are helpful for the diagnosis and management of systematic treatment …

Increasingly attention is being given to immune molecules in pancreatic cancer. The
purpose of this study was to understand the potential clinical application of immune …

Background The immune response in the tumor microenvironment (TME) plays a crucial role
in cancer progression and recurrence. We aimed to develop an immune-related gene (IRG) …

Purpose To identify an immune‐related long noncoding RNA (lncRNA) signature with
potential prognostic value for patients with pancreatic cancer. Methods Pancreatic cancer …

Pancreatic cancer remains to have a high mortality, which is partly due to the lack of effective
treatment strategies. In this study, genes with potential associations with …